Experience and quality you can trust.

Consult with our experts

With over 20 years experience as a Preclinical CRO, CBI has tissue cross-reactivity capabilities suitable for your unique research needs.

  • Three phases:
    • 1: Initial Characterization and Optimization
    • 2: Preliminary TCR Screening
    • 3: Full Cross-Reactivity Study (GLP)
  • Tissue bank of various species including transgenic/knockout models, diseased tissue and tumors; frozen and fixed tissues for human tissue cross-reactivity studies
  • Digital photomicroscopy, digital image analysis and histomorphometry
  • GLP and non-GLP studies
  • Expertise in immunohistochemistry, histology and immunopathology
  • Study-specific protocols prepared to reflect your exact requirements
  • Tissue evaluation by experienced ACVP board-certified veterinary pathologist

Our full service in vivo facility also offers:

  • Full range of tissues
  • On-site histopathology
  • Immunohistochemistry
  • In-house board-certified pathologist
  • Efficient, quality reporting
  • Archiving

Extensive experience with

  • Small molecules
  • Biologics
  • Immunotherapy
  • Stem cells
  • Devices and implants
  • Gene therapy

Standards of excellence

  • GLP equipped
  • AAALAC accredited
  • USDA, FDA and OLAW compliant

Consult with our experts

Fill out the form below to learn more about our tissue cross-reactivity capabilities